Farms.com Home   News

Cool, Wet Weather Halts Midwest Corn Planting


The U.S. Midwest will be cool and wet for at least the next 10 days, preventing farmers from planting corn through most of April, a forecaster said on Tuesday.

Up to an inch of rain fell in northern Iowa, eastern Nebraska and southeastern South Dakota since early Monday while the eastern Corn Belt received 0.25 to 0.75 inch of rain.

"The Midwest is not going to do well under this type of weather," said forecaster Joel Burgio with Telvent DTN weather service.

Farmers will be sidelined, waiting for soils to dry and warm up before they can resume planting corn and spring wheat.

All the rain is also raising Midwest river levels, forcing the closure of several locks on the upper Mississippi River, the main artery to transport Midwest grain to export terminals at the U.S. Gulf.

The U.S. Department of Agriculture said late Monday that 7 percent of the corn crop was seeded as Sunday, versus the 8 percent average for mid-April.

Additional rains will fall belt wide on Tuesday, up to an inch or more with the heaviest amounts falling in the eastern Corn Belt. Severe storms were forecast for the Ohio River Valley, with tornadoes possible by Tuesday night.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.